Format

Send to

Choose Destination
See comment in PubMed Commons below
Future Med Chem. 2011 May;3(7):881-6. doi: 10.4155/fmc.11.55.

Overview of the animal health drug development and registration process: an industry perspective.

Author information

1
Elanco Animal Health, Division of Eli Lilly & Co., 2500 Innovation Way, Greenfield, IN 46140, USA. hunterrp@lilly.com

Abstract

Products for animal health commercialization follow a structured progression from initial concept through to regulatory approval. Typically, products are developed for use in either food animals or companion animals. These can be for the intention of disease intervention, productivity enhancement or improvement in a quality of life capacity. The animal health industry is a regulated industry, meaning that a government agency is responsible for oversight of products, both pre- and post-approval. There are three primary US government agencies that ensure quality, safety and effectiveness for the approval of new products and post-marketing compliance.

PMID:
21644833
DOI:
10.4155/fmc.11.55
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center